Myxoid chondrosarcoma

Description: 
Available test Fluorescence in situ hybridisation analysis for EWSR1 t(22q12;)
Clinical details: 
Approximately 70% of cases of myxoid chondrosarcoma are charcterised by a translocation involving EWSR1, and detection of EWSR1 rearrangement may be useful when used alongside histology and immunohistochemistry in establishing the diagnosis in equivocal cases.
Synonyms or keywords: 
Myxoid chondrosarcoma EWS, EWSR1, NOR1, NR4A3, CHN
Department: 
Sample type and Volume required: 
FFPE tissue sections – 3-4µm sections on unstained Apes slides with appropriate IHC/H&E slide for correlation
Turnaround time: 
Current service turnaround times: Urgent 2-7 calendar days; Non-urgent 5-10 calendar days; National targets: Urgent samples 95% reported within 14 days; Non-urgent 95% reprted within 21 days
Contacts:
Oncology Cytogenetics Laboratory at Guy's Hospital
Genetics Department
Tower Wing - 5th Floor
Guy's Hospital
Great Maze Pond
London SE1 9RT

T: 020 7188 1715
For clinical advice or interpretation of results, please contact the laboratory in the first instance.

Print as a PDF

Last updated: 07/08/2015